cromakalim has been researched along with Heart Disease, Ischemic in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 46 (82.14) | 18.2507 |
2000's | 9 (16.07) | 29.6817 |
2010's | 1 (1.79) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carroll, WA; Coghlan, MJ; Gopalakrishnan, M | 1 |
Gao, JY; Ito, K; Ito, Y; Shimokawa, H; Shiroto, T; Tsuburaya, R; Yasuda, S | 1 |
Curtis, MJ; Hearse, DJ; Rees, SA; Tsuchihashi, K | 1 |
Kinoshita, M; Nakae, I; Quan, L; Sugimoto, Y; Tsutamoto, T | 1 |
Grover, GJ; Speechly-Dick, ME; Yellon, DM | 1 |
Abe, T; Arita, M; Saikawa, T; Sakata, T; Sato, T; Shigematsu, S | 1 |
D'Alonzo, AJ; Darbenzio, RB; Grover, GJ; Parham, CS | 2 |
Atwal, KS; D'Alonzo, AJ; Grover, GJ; McCullough, JR; Sargent, CA | 1 |
Dux, L; Ferdinandy, P; Koltai, M; Szilvássy, Z | 1 |
Grover, GJ | 2 |
D'Alonzo, AJ; Darbenzio, RB; Grover, GJ; Hess, TA; Sewter, JC; Sleph, PG | 1 |
Moore, TL; Shebuski, RJ; Toombs, CF | 1 |
Armstrong, JM; Bellemin-Baurreau, J; Hicks, PE; Poizot, A; Rochette, L | 1 |
Hellwig, B | 1 |
Cavero, I; Premmereur, J | 1 |
Allard, M; Braquet, PG; Ferdinandy, P; Jakab, I; Koltai, M; Lonovics, J; Szilvassy, Z; Tarrade, T | 1 |
Ahmed, SZ; Atwal, KS; Dzwonczyk, S; Ferrara, FN; Grover, GJ; Harper, TW; Kim, KS; Moreland, S; Russell, AD; Sleph, PG | 1 |
Das, DK; Engelman, RM; Szerdahelyi, P; Tosaki, A | 1 |
Nakaya, H | 1 |
Harada, K; Jinno, Y; Miwa, A; Nakazawa, H; Nishikori, K; Ogawa, N; Ohta, H | 1 |
Das, DK; Engelman, DT; Engelman, RM; Tosaki, A | 1 |
D'Alonzo, AJ; Darbenzio, RB; Grover, GJ; Hess, T; Sleph, PG | 1 |
Droy-Lefaix, MT; Ferdinandy, P; Koltai, M; Szilvássy, Z; Tarrade, T | 1 |
Grover, GJ; Sleph, PG | 1 |
Baird, AJ; Grover, GJ; Sleph, PG | 1 |
Dzwonczyk, S; Grover, GJ; Monticello, TM | 1 |
D'Alonzo, AJ; Darbenzio, RB; Grover, GJ; Hess, TA; Lodge, NJ; Normandin, DE; Sewter, JC; Sleph, PG | 1 |
Das, DK; Engelman, RM; Tosaki, A | 1 |
Chujo, M; Hori, M; Inoue, M; Kamada, T; Kitakaze, M; Komamura, K; Minamino, T; Mori, H; Node, K; Shinozaki, Y | 1 |
Escande, D; Henry, P; Hinescu, ME; Popescu, A; Pucéat, M | 1 |
Fleck, E; Henning, B; Hildebrandt, AG; Ott, T; Zünkler, BJ | 1 |
Deslauriers, R; Docherty, JC; Gunter, HE; Kuzio, B; Shoemaker, L; Yang, L | 1 |
Das, DK; Tosaki, A | 1 |
György, K; Kaszala, K; Papp, JG; Parratt, JR; Vegh, A | 1 |
Deutsch, NA; Goldhaber, JI; Khuu, K; Lamp, ST; Shivkumar, K; Weiss, JN | 1 |
Cho, TS; Jung, YS; Moon, CH; Shin, HS; Yoo, SE | 1 |
Ashraf, M; Miyawaki, H; Wang, Y | 1 |
Kamei, K; Kamijo, T; Kamiyama, T; Ohba, Y; Sudo, H; Sugo, I | 1 |
Cobbe, SM; Hicks, MN; Kane, KA; Wolk, R | 1 |
Chang, MJ; Chen, YC; Cheng, CY; Lee, YM; Peng, YY; Sheu, JR; Yen, MH | 1 |
Obata, T; Yamanaka, Y | 1 |
Avkiran, M; Coetzee, WA; Wells, T | 1 |
Ismail, JA; McDonough, KH | 1 |
Atwal, KS; Bajgar, R; D'Alonzo, AJ; Darbenzio, RB; Garlid, KD; Grover, GJ; Hess, TA; Lodge, NJ; Paucek, P; Sleph, PG; Smith, MA | 1 |
Coronel, R; de Groot, JR; de Jong, JW; Fiolet, JW; Remme, CA; Schumacher, CA; Wilde, AA | 1 |
de Hemptinne, A; Vanheel, B | 1 |
Galiñanes, M; Hearse, DJ; Shattock, MJ | 1 |
Wilde, AA | 1 |
Alexander, LD; Lamp, ST; Stuart, JS; Venkatesh, N; Weiss, JN | 1 |
Ahmed, SZ; Atwal, KS; Baird, AJ; Dzwonczyk, S; Grover, GJ; Normandin, DE; Sleph, PG | 1 |
Ahmed, SZ; Atwal, KS; Dzwonczyk, S; Ferrara, FN; Grover, GJ; Normandin, DE; Sleph, PG | 1 |
Ahmed, SZ; Atwal, KS; Ding, CZ; Grover, GJ; Kelly, Y; Miller, AV; Misra, RN; Normandin, DE; Rovnyak, GC; Sleph, PG | 1 |
Balsamo, A; Breschi, MC; Calderone, V; Digiacomo, M; Manganaro, M; Martelli, A; Minutolo, F; Rapposelli, S; Testai, L; Tonelli, F | 1 |
Calderone, V; Cirilli, R; Digiacomo, M; Faggi, C; La Torre, F; Manganaro, M; Martelli, A; Rapposelli, S; Testai, L | 1 |
5 review(s) available for cromakalim and Heart Disease, Ischemic
Article | Year |
---|---|
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
Topics: Adenosine Triphosphate; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Calcium; Ion Channel Gating; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Urinary Incontinence | 2001 |
Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Dihydropyridines; Disease Models, Animal; Dogs; Guanidines; Guinea Pigs; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Picolines; Pinacidil; Potassium Channels; Pyrans; Pyrroles; Rats; Vasodilator Agents | 1994 |
[Potassium agonists].
Topics: Animals; Benzopyrans; Calcium; Cromakalim; Humans; Membrane Potentials; Muscle, Smooth, Vascular; Myocardial Ischemia; Neuromuscular Junction; Niacinamide; Nicorandil; Potassium; Potassium Channels; Pyrroles; Vascular Resistance; Vasodilator Agents | 1994 |
[Potential role of ATP-sensitive K+ channels in ischemia- and reperfusion-induced arrhythmias].
Topics: Action Potentials; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Benzopyrans; Cromakalim; Glyburide; Guanidines; Humans; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Niacinamide; Nicorandil; Pinacidil; Potassium; Potassium Channels; Pyrroles; Tolbutamide | 1993 |
Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion.
Topics: Animals; ATP-Binding Cassette Transporters; Benzopyrans; Cromakalim; Guanidines; Humans; Ischemic Preconditioning, Myocardial; KATP Channels; Mitochondria, Heart; Models, Cardiovascular; Myocardial Ischemia; Myocardial Reperfusion; Niacinamide; Nicorandil; Picolines; Pinacidil; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyrans; Pyrroles; Rats | 1997 |
51 other study(ies) available for cromakalim and Heart Disease, Ischemic
Article | Year |
---|---|
Eicosapentaenoic acid reduces ischemic ventricular fibrillation via altering monophasic action potential in pigs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cromakalim; Disease Models, Animal; Eicosapentaenoic Acid; Fatty Acids; Gene Expression Regulation; Male; Myocardial Ischemia; Parasympatholytics; Potassium Channels, Inwardly Rectifying; Swine; Ventricular Fibrillation | 2011 |
Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.
Topics: Animals; Anti-Arrhythmia Agents; Benzopyrans; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Cromakalim; Cyclopropanes; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Heart Rate; Hemodynamics; In Vitro Techniques; Injections, Intravenous; Male; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Wistar; Vasodilator Agents; Ventricular Fibrillation | 1993 |
Glibenclamide-induced oscillation of canine coronary artery is independent of myocardial ischemia.
Topics: Adenosine Triphosphate; Animals; Arginine; Benzopyrans; Coronary Circulation; Coronary Vessels; Cromakalim; Diltiazem; Dogs; Female; Glyburide; In Vitro Techniques; Male; Muscle Tonus; Muscle, Smooth, Vascular; Myocardial Ischemia; Niacinamide; Nicorandil; Nitroarginine; Nitroglycerin; Potassium Channels; Pyrroles; Vasodilator Agents | 1994 |
Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Studies of contractile function after simulated ischemia in an atrial in vitro model.
Topics: Adenosine Triphosphate; Adult; Aged; Alkaloids; Benzophenanthridines; Benzopyrans; Cromakalim; Diglycerides; Female; Heart Atria; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Phenanthridines; Potassium Channels; Protein Kinase C; Pyrroles; Random Allocation; Time Factors | 1995 |
Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protective role against myocardial stunning.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Benzopyrans; Cromakalim; Glyburide; Guinea Pigs; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardial Stunning; Myocardium; Perfusion; Potassium Channels; Pyrroles | 1995 |
Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential duration.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Benzopyrans; Cromakalim; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Infusions, Intravenous; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Phenethylamines; Potassium Channels; Pyrroles; Regional Blood Flow; Sulfonamides | 1995 |
Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Aorta; Benzopyrans; Cromakalim; Decanoic Acids; Dogs; Female; Glyburide; Guanidines; Guinea Pigs; Heart; Heart Ventricles; Hydroxy Acids; In Vitro Techniques; Injections, Intravenous; Injections, Subcutaneous; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1995 |
Ventricular overdrive pacing-induced preconditioning and no-flow ischemia-induced preconditioning in isolated working rat hearts.
Topics: Animals; Benzopyrans; Blood Pressure; Cardiac Pacing, Artificial; Coronary Circulation; Cromakalim; Disease Models, Animal; Glyburide; Heart; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Potassium Channels; Pyrroles; Rats; Rats, Wistar; Vasodilator Agents | 1995 |
Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia.
Topics: Animals; Arrhythmias, Cardiac; Benzopyrans; Cromakalim; Glyburide; Guanidines; Heart; Heart Rate; Myocardial Ischemia; Myocardial Reperfusion Injury; Perfusion; Pinacidil; Potassium; Pyrroles; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1994 |
Cardioprotection with U-89232 is not reversible with glibenclamide: evidence of a novel anti-ischemic agent derived from cromakalim.
Topics: Animals; Benzopyrans; Cromakalim; Female; Glyburide; Guanidines; Heart; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Necrosis; Potassium Channels; Pyrroles; Rabbits; Vasodilator Agents | 1994 |
Effects of ATP-dependent K+ channel modulators on an ischemia-reperfusion rabbit isolated heart model with programmed electrical stimulation.
Topics: Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Benzopyrans; Blood Pressure; Coronary Circulation; Cromakalim; Electric Stimulation; Glyburide; Heart; In Vitro Techniques; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channels; Pyrroles; Rabbits; Refractory Period, Electrophysiological; Vasodilator Agents | 1994 |
ATP sensitive potassium channel openers are of potential benefit in ischaemic heart disease.
Topics: Benzopyrans; Cromakalim; Dihydropyridines; Guanidines; Humans; Myocardial Ischemia; Myocardium; Niacinamide; Nicorandil; Picolines; Pinacidil; Potassium Channels; Pyrans; Pyrroles; Sodium-Potassium-Exchanging ATPase; Vasodilator Agents | 1994 |
Cromakalim and cicletanine against pacing-induced myocardial ischemia in conscious rabbits.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Blood Pressure; Cardiac Pacing, Artificial; Consciousness; Cromakalim; Heart Rate; Male; Myocardial Ischemia; Potassium Channels; Pyridines; Pyrroles; Rabbits; Stroke Volume; Vasodilator Agents; Ventricular Function, Left | 1994 |
Cardioselective anti-ischemic ATP-sensitive potassium channel openers.
Topics: Adenosine Triphosphate; Animals; Aorta; Benzopyrans; Biological Availability; Cocaine; Cromakalim; Guanidines; Ion Channel Gating; Molecular Structure; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Structure-Activity Relationship; Vasodilation | 1993 |
Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
Topics: Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Benzopyrans; Cations; Cromakalim; Glyburide; Heart; Ion Channel Gating; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley | 1993 |
Effects of K+ channel openers on ischemic dysfunction and metabolic disturbance in isolated perfused rat heart.
Topics: Animals; Benzopyrans; Cromakalim; Heart; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion; Pyridines; Pyrroles; Rats; Rats, Wistar; Vasodilator Agents | 1993 |
Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzopyrans; Cations; Cromakalim; Diabetes Mellitus, Experimental; Glyburide; Heart Function Tests; Hypoglycemic Agents; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Potassium Channel Blockers; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley; Streptozocin | 1995 |
Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Female; Glyburide; Guanidines; Guinea Pigs; In Vitro Techniques; Ion Channel Gating; Male; Membrane Potentials; Myocardial Infarction; Myocardial Ischemia; Perfusion; Potassium Channels; Pyrroles; Vasodilator Agents | 1995 |
KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
Topics: Animals; Anti-Arrhythmia Agents; Benzopyrans; Coronary Circulation; Coronary Disease; Cromakalim; Glyburide; Heart; Ion Channel Gating; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channels; Pyridines; Pyrroles; Rats; Rats, Wistar; Ventricular Fibrillation | 1995 |
Protective effect of K(ATP) openers in ischemic rat hearts treated with a potassium cardioplegic solution.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Cardioplegic Solutions; Cromakalim; Guanidines; Heart; Male; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley | 1995 |
Lack of a pharmacologic interaction between ATP-sensitive potassium channels and adenosine A1 receptors in ischemic rat hearts.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Dose-Response Relationship, Drug; Glyburide; Male; Myocardial Ischemia; Myocardium; Perfusion; Phenylisopropyladenosine; Potassium Channels; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Xanthines | 1996 |
Comparative cardioprotective effects of cromakalim and diltiazem in ischemic hypertrophied rat hearts.
Topics: Animals; Benzopyrans; Blood Pressure; Cardiomegaly; Cromakalim; Diltiazem; Heart; Heart Rate; L-Lactate Dehydrogenase; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Pyrroles; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Ventricular Function, Left | 1996 |
A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog.
Topics: Animals; Anti-Arrhythmia Agents; Aorta, Thoracic; Benzopyrans; Blood Pressure; Cardiotonic Agents; Cromakalim; Dogs; Electrophysiology; Guanidines; Heart; Heart Conduction System; Heart Rate; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Species Specificity | 1995 |
Effects of cromakalim and glibenclamide in ischemic and reperfused hearts.
Topics: Animals; Anti-Arrhythmia Agents; Benzopyrans; Cromakalim; Diabetes Mellitus, Experimental; Glyburide; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Pyrroles; Rats; Rats, Sprague-Dawley | 1996 |
Role of activation of ectosolic 5'-nucleotidase in the cardioprotection mediated by opening of K+c channels.
Topics: 5'-Nucleotidase; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Dogs; Enzyme Activation; Glyburide; Heart; Hemodynamics; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Niacinamide; Nicorandil; Potassium Channels; Pyrroles; Recurrence | 1996 |
Acute simulated ischaemia produces both inhibition and activation of K+ currents in isolated ventricular myocytes.
Topics: Action Potentials; Animals; Benzopyrans; Cromakalim; Hydrogen-Ion Concentration; Ischemic Preconditioning, Myocardial; Myocardial Ischemia; Myocardium; Patch-Clamp Techniques; Potassium Channels; Pyrroles; Rats; Sodium-Potassium-Exchanging ATPase | 1996 |
Effects of tolbutamide on ATP-sensitive K+ channels from human right atrial cardiac myocytes.
Topics: Adenosine Triphosphate; Adolescent; Adult; Aged; Atrial Function, Right; Benzopyrans; Child; Cromakalim; Drug Interactions; Female; Heart Atria; Humans; Hypoglycemic Agents; Kinetics; Male; Membrane Potentials; Middle Aged; Myocardial Ischemia; Myocardium; Potassium Channels; Pyrroles; Sensitivity and Specificity; Tolbutamide | 1997 |
Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Benzopyrans; Coronary Circulation; Cromakalim; Decanoic Acids; Dose-Response Relationship, Drug; Glyburide; Hydrogen-Ion Concentration; Hydroxy Acids; Hypoglycemic Agents; In Vitro Techniques; Lactates; Magnetic Resonance Spectroscopy; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Phosphorus Isotopes; Pyrroles; Rats; Rats, Sprague-Dawley | 1997 |
Extracellular Mg++ manipulation prevents the proarrhythmic activity of cromakalim in ischemic/reperfused diabetic hearts.
Topics: Animals; Arrhythmias, Cardiac; Benzopyrans; Calcium; Cromakalim; Diabetes Mellitus, Experimental; Heart; Magnesium; Male; Myocardial Ischemia; Myocardial Reperfusion; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley; Sodium; Streptozocin | 1997 |
Does the opening of ATP-sensitive K+ channels modify ischaemia-induced ventricular arrhythmias in anaesthetised dogs?
Topics: Adenosine Triphosphate; Anesthesia; Animals; Arrhythmias, Cardiac; Coronary Circulation; Cromakalim; Dogs; Female; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channels; Vasodilator Agents | 1997 |
Mechanism of hypoxic K loss in rabbit ventricle.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Biological Transport; Cromakalim; Glyburide; Heart Ventricles; Hypoxia; In Vitro Techniques; Ion Channel Gating; Male; Models, Biological; Myocardial Ischemia; Potassium; Potassium Channel Blockers; Potassium Channels; Rabbits; Sodium | 1997 |
Cardioprotective effects of KR-30450, a novel K+(ATP) opener, and its major metabolite KR-30818 on isolated rat hearts.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Cromakalim; Dose-Response Relationship, Drug; Glyburide; Heart; Heart Rate; Hypoglycemic Agents; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channel Blockers; Potassium Channels; Pyrimidines; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasodilator Agents | 1998 |
Oxidant stress with hydrogen peroxide attenuates calcium paradox injury: role of protein kinase C and ATP-sensitive potassium channel.
Topics: Adenosine Triphosphate; Alkaloids; Animals; Anti-Arrhythmia Agents; Benzophenanthridines; Calcium; Cromakalim; Enzyme Inhibitors; Glyburide; Hemodynamics; Hydrogen Peroxide; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardium; Perfusion; Phenanthridines; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate | 1998 |
Hemodynamic and hormonal responses to nicorandil in a canine model of acute ischemic heart failure: a comparison with cromakalim and nitroglycerin.
Topics: Acute Disease; Animals; Atrial Natriuretic Factor; Cardiac Output, Low; Cromakalim; Dogs; Embolization, Therapeutic; Female; Hemodynamics; Hormones; Male; Microspheres; Myocardial Ischemia; Natriuretic Peptide, Brain; Nicorandil; Nitroglycerin; Potassium Channels; Renin; Vasodilator Agents | 1999 |
Relevance of inter- and intraventricular electrical dispersion to arrhythmogenesis in normal and ischaemic rabbit myocardium: a study with cromakalim, 5-hydroxydecanoate and glibenclamide.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Cromakalim; Decanoic Acids; Glyburide; Heart; Hydroxy Acids; In Vitro Techniques; Male; Myocardial Ischemia; Potassium Channels; Rabbits; Refractory Period, Electrophysiological; Ventricular Fibrillation | 1999 |
The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener.
Topics: Adenosine Triphosphate; Animals; Antihypertensive Agents; Aorta, Thoracic; Arrhythmias, Cardiac; Benzopyrans; Blood Pressure; Cromakalim; Dose-Response Relationship, Drug; Heart; Heart Rate; Hemodynamics; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channels; Pyrrolidinones; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Vasodilation; Vasodilator Agents; Ventricular Fibrillation | 2000 |
Block of cardiac ATP-sensitive K(+) channels reduces hydroxyl radicals in the rat myocardium.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Cromakalim; Decanoic Acids; Dose-Response Relationship, Drug; Ferrous Compounds; Glyburide; Hydroxy Acids; Hydroxybenzoates; Hydroxyl Radical; Hypoglycemic Agents; Inhibitory Concentration 50; Iron Chelating Agents; Male; Microdialysis; Myocardial Ischemia; Myocardium; Nicorandil; Potassium Channel Blockers; Rats; Rats, Wistar; Salicylates; Time Factors | 2000 |
Anti-arrhythmic effects of levcromakalim in the ischaemic rat heart: a dual mechanism of action?
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; ATP-Binding Cassette Transporters; Coronary Circulation; Cromakalim; Heart Rate; In Vitro Techniques; KATP Channels; Male; Myocardial Ischemia; NADP; Phosphocreatine; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar | 2000 |
The role of K+ATP channels in the control of pre- and post-ischemic left ventricular developed pressure in septic rat hearts.
Topics: Animals; ATP-Binding Cassette Transporters; Blood Pressure; Coronary Circulation; Cromakalim; Escherichia coli Infections; Glyburide; Hypoglycemic Agents; KATP Channels; Myocardial Contraction; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Sepsis; Stroke Volume; Vasodilator Agents; Ventricular Function, Left | 2001 |
Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Topics: Action Potentials; Animals; Benzopyrans; Cardiovascular Agents; Cromakalim; Decanoic Acids; Dose-Response Relationship, Drug; Glyburide; Guanidines; Guinea Pigs; Heart; Heart Conduction System; Hydroxy Acids; Imidazoles; In Vitro Techniques; Male; Mitochondria; Myocardial Ischemia; Myocardial Reperfusion; Papillary Muscles; Patch-Clamp Techniques; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Vasodilator Agents; Vasomotor System | 2001 |
K(ATP) channel opening during ischemia: effects on myocardial noradrenaline release and ventricular arrhythmias.
Topics: Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Coronary Circulation; Cromakalim; Female; Glyburide; Heart; Heart Ventricles; Hypoglycemic Agents; In Vitro Techniques; Male; Myocardial Ischemia; Myocardium; Norepinephrine; Potassium; Potassium Channels; Rabbits; Time Factors; Vasodilator Agents | 2001 |
Influence of KATP channel modulation on net potassium efflux from ischaemic mammalian cardiac tissue.
Topics: Action Potentials; Animals; Barium; Benzopyrans; Cromakalim; Glyburide; Guinea Pigs; Hydrogen-Ion Concentration; Muscles; Myocardial Ischemia; Oxygen; Papillary Muscles; Potassium; Potassium Channels; Pyrroles; Tolbutamide; Vasodilator Agents | 1992 |
Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration.
Topics: Action Potentials; Animals; Benzopyrans; Blood Pressure; Coronary Circulation; Coronary Vessels; Cromakalim; Dogs; Glyburide; Myocardial Contraction; Myocardial Ischemia; Pyrroles; Vasodilator Agents | 1992 |
Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia.
Topics: Animals; Benzopyrans; Blood Pressure; Coronary Circulation; Coronary Vessels; Cromakalim; Glyburide; Heart Arrest, Induced; Myocardial Contraction; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Wistar; Vasodilator Agents | 1992 |
KATP channel opening and cardioprotection.
Topics: Benzopyrans; Cromakalim; Humans; Myocardial Ischemia; Potassium Channels; Pyrroles; Vasodilator Agents | 1992 |
Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Female; Heart; Heart Ventricles; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Parasympatholytics; Potassium; Potassium Channels; Pyrroles; Rabbits; Vasodilator Agents | 1992 |
Cardioselective anti-ischemic ATP-sensitive potassium channel openers. 3. Structure-activity studies on benzopyranyl cyanoguanidines: modification of the cyanoguanidine portion.
Topics: Adenosine Triphosphate; Animals; Guanidines; In Vitro Techniques; Magnetic Resonance Spectroscopy; Myocardial Ischemia; Potassium Channels; Rats; Structure-Activity Relationship; Vasodilator Agents | 1995 |
Cardioselective antiischemic ATP-sensitive potassium channel openers. 2. Structure-activity studies on benzopyranylcyanoguanidines: modification of the benzopyran ring.
Topics: Adenosine Triphosphate; Animals; Aorta; Benzopyrans; Guanidines; Heart; Ion Channel Gating; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Ischemia; Potassium Channels; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Sensitivity and Specificity; Structure-Activity Relationship | 1995 |
Cardioselective antiischemic ATP-sensitive potassium channel (K(ATP)) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines.
Topics: Animals; Benzopyrans; Cardiotonic Agents; Glyburide; Guanidines; Heart; Muscle Contraction; Myocardial Ischemia; Potassium Channels; Rats; Vasodilation; Vasodilator Agents | 1999 |
Spirocyclic benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel.
Topics: Animals; Benzopyrans; Blood Pressure; KATP Channels; Male; Mitochondria; Molecular Structure; Myocardial Ischemia; Rats; Rats, Wistar; Spiro Compounds; Structure-Activity Relationship | 2008 |
Enantioselectivity in cardioprotection induced by (S)- (-)-2,2-dimethyl-N-(4'-acetamido-benzyl)-4-spiromorpholone-chromane.
Topics: Animals; Benzopyrans; Cardiotonic Agents; Chromatography, High Pressure Liquid; Circular Dichroism; Crystallography, X-Ray; In Vitro Techniques; Models, Molecular; Molecular Conformation; Myocardial Ischemia; Myocardial Reperfusion; Rats; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship | 2009 |